Peginesatide acetate - Generic Drug Details

✉ Email this page to a colleague

▶ Start for $1
Remove trial restrictions

What are the generic sources for peginesatide acetate and what is the scope of patent protection?

Peginesatide acetate is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Peginesatide acetate has one hundred and fourteen patent family members in thirty-four countries.

US Patents and Regulatory Information for peginesatide acetate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Takeda Pharms Usa	OMONTYS PRESERVATIVE FREE	peginesatide acetate	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	202799-006	Mar 27, 2012		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Takeda Pharms Usa	OMONTYS PRESERVATIVE FREE	peginesatide acetate	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	202799-002	Mar 27, 2012		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Takeda Pharms Usa	OMONTYS PRESERVATIVE FREE	peginesatide acetate	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	202799-006	Mar 27, 2012		DISCN	No	No	See Plans and Pricing	See Plans and Pricing	Y	Y		See Plans and Pricing
Takeda Pharms Usa	OMONTYS PRESERVATIVE FREE	peginesatide acetate	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	202799-001	Mar 27, 2012		DISCN	No	No	See Plans and Pricing	See Plans and Pricing	Y	Y		See Plans and Pricing
Takeda Pharms Usa	OMONTYS PRESERVATIVE FREE	peginesatide acetate	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	202799-005	Mar 27, 2012		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Takeda Pharms Usa	OMONTYS PRESERVATIVE FREE	peginesatide acetate	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	202799-004	Mar 27, 2012		DISCN	No	No	See Plans and Pricing	See Plans and Pricing	Y	Y		See Plans and Pricing
Takeda Pharms Usa	OMONTYS	peginesatide acetate	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	202799-008	Mar 27, 2012		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	2004101606		See Plans and Pricing
Singapore	162747	ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES	See Plans and Pricing
Croatia	P20090251		See Plans and Pricing
Cyprus	1113442		See Plans and Pricing
Brazil	PI0411172	peptìdeo, dìmero de peptìdeo, seu uso e composição farmacêutica	See Plans and Pricing
Eurasian Patent Organization	200501798	НОВЫЕ ПЕПТИДЫ, КОТОРЫЕ СВЯЗЫВАЮТСЯ С РЕЦЕПТОРОМ К ЭРИТРОПОЭТИНУ	See Plans and Pricing
Iceland	8167	Peptíð sem bindast rauðkornavakaviðtakanum	See Plans and Pricing
>Country	>Patent Number	>Title	>Estimated Expiration

Country

Patent Number

Title

Estimated Expiration

World Intellectual Property Organization (WIPO)

2004101606

See Plans and Pricing

Singapore

162747

ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES

See Plans and Pricing

Croatia